{"favorite_id": 10062, "calc_type": "", "dosing": false, "full_title_en": "Fleischner Society Guidelines for Incidental Pulmonary Nodules", "short_title_en": "Fleischner Guidelines for Pulmonary Nodules", "medium_description_en": "<span id=\"docs-internal-guid-75dc5fec-aaeb-9cf2-4a58-c105fabdc83c\">Provides guidelines for management of solid and subsolid pulmonary nodules.</span>", "short_description_en": "Pulmonary nodule management.", "before_use": "", "instructions_en": "<p><span id=\"docs-internal-guid-1707ff55-aaec-ab68-f189-c5d31820ce87\">Use in patients &ge;35 years old with incidental pulmonary nodules on CT imaging. Do not use for lung cancer screening or in patients with known primary cancer or immunosuppression.&nbsp;</span>Use most suspicious nodule as guide to management.&nbsp;</p>", "purpose_en": ["Treatment"], "disease_en": ["Lung Cancer"], "specialty_en": ["Pulmonology", "Hematology and Oncology", "Hospitalist Medicine", "Infectious Disease", "Internal Medicine"], "chief_complaint_en": ["Chest Pain", "Cough", "Shortness of Breath", "Weight Loss/Gain"], "system_en": ["Infectious", "Oncologic", "Respiratory"], "search_abbreviation_en": ["pulmonary nodules", "pulmonary nodule management", "pulmonary nodule treatment", "recommendation", "lung nodules", "incidental lung nodules", "fleischner criteria", "fleischner"], "slug": "fleischner-society-guidelines-incidental-pulmonary-nodules", "seo": {"meta_description_en": "The Fleischner Society Guidelines for Incidental Pulmonary Nodules provides guidelines for management of solid and subsolid pulmonary nodules.", "keywords_en": "Fleischner society guidelines, pulmonary nodules, pulmonary nodule management, pulmonary nodule treatment, recommendation, lung cancer"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-23248b84-aafd-702d-77bc-5c1fc25dde85\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Patients &ge;35 years old with incidental pulmonary nodules on CT scan.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Do not use for lung cancer screening or in patients with known primary cancer or immunosuppression.</p>\n</li>\n</ul>", "pearls_pitfalls_en": "", "why_use_en": "<p><span id=\"docs-internal-guid-26d79e07-aafd-b7d8-39f4-28e38a1ef0d6\">Incidental pulmonary nodules on imaging can be challenging to evaluate. These guidelines provide an accepted framework for management.</span></p>"}, "next_steps": {"advice_en": "<p>The Fleischner Society recommends that incidental nodules in patients &lt;35 years old be managed on a case-by-case basis, as infectious causes are more likely than cancer (and therefore serial CT to monitor should be limited).</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p dir=\"ltr\">Choose the appropriate features. For nodule size, use the average of long and short axes and round to the nearest millimeter.</p>\n<p dir=\"ltr\"><strong>Solid nodules:</strong></p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /><col width=\"*\" /></colgroup>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\"><strong>Size</strong></p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Single</strong></p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Multiple</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Low risk*</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>High risk*</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Low risk*</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>High risk*</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&lt;6 mm (&lt;100 mm3)</p>\n</td>\n<td>\n<p dir=\"ltr\">No routine follow-up</p>\n</td>\n<td>\n<p dir=\"ltr\">Optional CT at 12 months</p>\n</td>\n<td>\n<p dir=\"ltr\">No routine follow-up</p>\n</td>\n<td>\n<p dir=\"ltr\">Optional CT at 12 months</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">6-8 mm (100-250 mm3)</p>\n</td>\n<td>\n<p dir=\"ltr\">CT at 6-12 months, then consider CT at 18-24 months</p>\n</td>\n<td>\n<p dir=\"ltr\">CT at 6-12 months, then CT at 18-24 months</p>\n</td>\n<td>\n<p dir=\"ltr\">CT at 3-6 months, then consider CT at 18-24 months</p>\n</td>\n<td>\n<p dir=\"ltr\">CT at 3-6 months, then at 18-24 months</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;8 mm (&gt;250 mm3)</p>\n</td>\n<td>\n<p dir=\"ltr\">Consider CT at 3 months, PET/CT, or tissue sampling</p>\n</td>\n<td>\n<p dir=\"ltr\">Consider CT at 3 months, PET/CT, or tissue sampling</p>\n</td>\n<td>\n<p dir=\"ltr\">CT at 3-6 months, then consider CT at 18-24 months</p>\n</td>\n<td>\n<p dir=\"ltr\">CT at 3-6 months, then at 18-24 months</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p dir=\"ltr\"></p>\n<p dir=\"ltr\"><strong>Subsolid nodules:</strong></p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"*\" /><col width=\"108\" /><col width=\"121\" /><col width=\"38\" /><col width=\"*\" /></colgroup>\n<tbody>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\"><strong>Size</strong></p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Single</strong></p>\n</td>\n<td colspan=\"2\" rowspan=\"2\">\n<p dir=\"ltr\"><strong>Multiple</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Ground glass</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Part solid</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&lt;6 mm (&lt;100 mm3)</p>\n</td>\n<td>\n<p dir=\"ltr\">No routine follow-up</p>\n</td>\n<td>\n<p dir=\"ltr\">No routine follow-up</p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\">CT at 3-6 months. If stable, consider CT at 2 and 4 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&ge;6 mm (&ge;100 mm3)</p>\n</td>\n<td>\n<p dir=\"ltr\">CT at 6-12 months to confirm persistence, then CT every 2 years until 5 years</p>\n</td>\n<td>\n<p dir=\"ltr\">CT at 3-6 months to confirm persistence. If unchanged and solid component remains &lt;6 mm, annual CT should be performed for 5 years</p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\">CT at 3-6 months. Subsequent management based on the most suspicious nodule(s)</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p dir=\"ltr\"></p>\n<p dir=\"ltr\">*Risk level is determined by clinical judgment, and all relevant risk factors should be considered, including:</p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Nodule size, morphology, location, multiplicity, growth rate, presence of emphysema, and evidence of fibrosis.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Age, race, sex, and family history of lung cancer.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Smoking status and exposure to other inhaled carcinogens.</p>\n</li>\n</ul>", "more_info_en": "", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "https://pubs.rsna.org/doi/pdf/10.1148/radiol.2017161659", "text": "Macmahon H, Naidich DP, Goo JM, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology. 2017;:161659."}], "Other References": [{"href": "", "text": ""}], "Validation": [{"href": "", "text": ""}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Heber MacMahon", "creator_info": {"about_en": "<p>Heber MacMahon, MB, BCh, is the section chief of thoracic radiology and a professor of radiology at the University of Chicago Medicine. He is also a leader in the University of Chicago Comprehensive Cancer Center's Advanced Imaging Program. Dr. MacMahon\u2019s primary research is focused on thoracic diagnostic radiology, lung cancer detection, and computer-aided diagnosis.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-heber-macmahon.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=MacMahon+H%5Bau%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Nodule type", "name": "nodule", "options": [{"label": "Solid", "value": 0}, {"label": "Subsolid", "value": 1}], "conditionality": "", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Number of nodules", "name": "type", "options": [{"label": "Single", "value": 0}, {"label": "Multiple", "value": 1}], "conditionality": "", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Risk level", "name": "level", "options": [{"label": "Low", "value": 0}, {"label": "High", "value": 1}], "conditionality": "nodule == 0", "show_points": false, "tips_en": "Use clinical judgment and consider all relevant factors, including size, morphology, patient age, race, smoking status, etc (see <a href=\"#evidence\">Evidence</a> for details)", "optional": false}, {"type": "radio", "label_en": "Additional features", "name": "features", "options": [{"label": "Ground glass", "value": 0}, {"label": "Part solid", "value": 1}], "conditionality": "nodule == 1 && type == 0 ", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Size", "name": "size1", "options": [{"label": "<6 mm (<100 mm\u00b3)", "value": 0}, {"label": "6-8 mm (100-250 mm\u00b3)", "value": 1}, {"label": ">8 mm (>250 mm\u00b3)", "value": 2}], "conditionality": "nodule == 0", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Size", "name": "size2", "options": [{"label": "<6 mm (<100 mm\u00b3)", "value": 0}, {"label": "\u22656 mm (\u2265100 mm\u00b3)", "value": 1}], "conditionality": "nodule == 1", "show_points": false, "optional": false}], "md5": "11b9cd913aaf3da63425b4276fc8b816", "related_calcs": [{"calcId": 4057, "short_title_en": "Solitary Pulmonary Nodule Malignancy Risk (Mayo)", "slug": "solitary-pulmonary-nodule-spn-malignancy-risk-score-mayo-clinic-model"}, {"calcId": 4055, "short_title_en": "RADS for Smoke Inhalation Injury", "slug": "rads-radiologists-score-smoke-inhalation-injury"}, {"calcId": 3918, "short_title_en": "Hestia Criteria", "slug": "hestia-criteria-outpatient-pulmonary-embolism-treatment"}]}